Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Covington
Fish and Richardson
Moodys
Colorcon
US Department of Justice
Daiichi Sankyo
Accenture

Generated: July 19, 2018

DrugPatentWatch Database Preview

AZULFIDINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Azulfidine patents expire, and what generic alternatives are available?

Azulfidine is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
Drug patent expirations by year for AZULFIDINE
Pharmacology for AZULFIDINE
Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Synonyms for AZULFIDINE
(3Z)-6-Oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid
(Z)-6-oxo-3-(2-(4-(N-(pyridin-2-yl)sulfamoyl)phenyl)hydrazono)cyclohexa-1,4-diene-1-carboxylic acid
13gs
2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
2-hydroxy-5-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl)benzoic acid
2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid
2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid
3XC8GUZ6CB
4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
4-(Pyridyl-2-amidosulfonyl)-3''-carboxy-4''-hydroxyazobenzene
5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid
5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid
5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid
5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid
5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid
5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid
5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid
5-22-08-00433 (Beilstein Handbook Reference)
599-79-1
AB2000147
AC1NSE0P
AC1Q72VB
Accucol
AKOS026749974
Alphapharm Brand of Sulfasalazine
Alti-Sulfasalazine
Ashbourne Brand of Sulfasalazine
Asulfidine
Azlufidine EN-Tabs
Azopyrin
Azopyrine
Azosulfidin
Azulfadine
Azulfidine (TN)
Azulfidine EN-tabs
Azulfidine;Salazopyrin;Sulphasalazine
BDBM50097125
Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-
Benzoic acid, 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]-
Benzosulfa
BIDD:GT0161
BRD-K10670311-001-06-4
BRN 0356241
C07316
CAS-599-79-1
CCRIS 4713
CHEBI:9334
CHEBI:94500
CHEMBL242373
Colo Pleon
Colo-Pleon
CPD000059146
D00448
D02ZTJ
D0GH2C
DB00795
DSSTox_CID_1256
DSSTox_GSID_21256
DSSTox_RID_76043
DTXSID0021256
EINECS 209-974-3
EN, Azulfidine
FNA Brand of Sulfasalazine
Henning Berlin Brand of Sulfasalazine
Heyl Brand of Sulfasalazine
HMS1569H21
HSDB 3395
I06-0676
KB-79573
KM0360
medac Brand of Sulfasalazine
NCGC00016518-01
NCGC00090903-01
NCGC00090903-02
NCGC00090903-03
NCGC00090903-04
NCGC00090903-05
NCGC00090903-06
NCGC00090903-07
NCGC00090903-11
NCGC00254313-01
NCGC00258791-01
NSC 203730
NSC 667219
NSC-203730
NSC203730
Pfizer Brand of Sulfasalazine
Pleon
PMS-Sulfasalazine
Pms-Sulfasalazine E.C.
Prestwick_848
Pyralin EN
ratio Sulfasalazine
ratio-Sulfasalazine
Ratiopharm Brandof Sulfasalazine
Reupirin
S.A.S. 500
S.A.S. Enteric-500
S.A.S.-500
S0580
s1576
Salazo-sulfapyridinum
Salazopiridazin
Salazopyridin
Salazopyrin
Salazopyrin (TN)
Salazopyrin EN-Tabs
Salazosulfapiridina
Salazosulfapiridina [INN-Spanish]
Salazosulfapyridin
Salazosulfapyridine
Salazosulfapyridine (JP15)
Salazosulfapyridine (JP17)
Salazosulfapyridinum
Salazosulfapyridinum [INN-Latin]
Salicylazosulfapyridine
Salicylic acid, 5-((p-(2-pyridylsulfamoyl)phenyl)azo)-
Salicylic acid, 5-[[p-(2-pyridylsulfamoyl)phenyl]azo]-
Salisulf
SAM001246530
Sanofi Synthelabo Brand of Sulfasalazine
Sas-500
SASP
SC-45949
SCHEMBL10289061
SCHEMBL1079598
SCHEMBL1229516
SCHEMBL4515
SI-88
Sulcolon
Sulfasalazin
Sulfasalazin Heyl
Sulfasalazin medac
Sulfasalazin-Heyl
Sulfasalazina
Sulfasalazina [INN-Spanish]
sulfasalazine
Sulfasalazine (Azulfidine)
Sulfasalazine (USP/INN)
Sulfasalazine [USAN:INN]
Sulfasalazine FNA
Sulfasalazine Pfizer Brand
Sulfasalazinum
Sulfasalazinum [INN-Latin]
sulfasalizine
Sulfazalazine
Sulphasalazine
Sulphasalazine, N-
Tox21_111037
Tox21_111037_1
Tox21_201239
Tox21_300541
TR-020767
Ucine
Ulcol
UNII-3XC8GUZ6CB
VA11798
w-t Sasp oral
WLN: T6NJ BSWMR DNUNR DQ CVQ
ZINC100030102

US Patents and Regulatory Information for AZULFIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn AZULFIDINE sulfasalazine SUSPENSION;ORAL 018605-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn AZULFIDINE sulfasalazine TABLET;ORAL 007073-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073-002 Apr 6, 1983 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Colorcon
Cantor Fitzgerald
Dow
Healthtrust
Deloitte
AstraZeneca
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.